Filing Details

Accession Number:
0001127602-20-028232
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-05 15:51:07
Reporting Period:
2020-03-23
Accepted Time:
2020-11-05 15:51:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1100682 Charles River Laboratories International Inc. CRL Services-Commercial Physical & Biological Research (8731) 061397316
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1688104 D William Barbo 251 Ballardvale Street
Wilmington MA 01887
Corporate Executive Vp & Cco No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-03-23 12,151 $0.00 5,899 No 5 G Direct
Common Stock Acquisiton 2020-03-23 12,151 $0.00 12,151 No 5 G Indirect By Trust
Common Stock Disposition 2020-10-30 180 $0.00 11,971 No 5 G Indirect By Trust
Common Stock Disposition 2020-11-03 2,150 $236.29 9,821 No 4 S Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Direct
No 5 G Indirect By Trust
No 5 G Indirect By Trust
No 4 S Indirect By Trust
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $236.267 to $236.361. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.